Go To Global Site
Welcome to UCB in the United States

Dec

17

UCB Hosts Patients to Share the Art of Advocacy

In September, our Raleigh-Durham office hosted their first Art of Advocacy event, which explored how art can be used as a platform for advocacy. The event showcased three artists, from across the U.S., living with a chronic illness, who use art as a medium to cope, spread awareness, and encourage others. We invite you to meet them and learn more about their stories below.

Neuro_Clinical_Fellowship_Image_1280x960

Dec

10

UCB-UNC-Duke Neurology Clinical Development Program

(Left to Right) Dr. Michael Markowitz (UCB), Dr. Shruti Raja, and Dr. Robert Dupuis (UNC Eshelman School of Pharmacy)

An important part of the drug development continuum is ensuring trained specialists are engaged through discovery, development, and delivery. Neurotherapeutics, or treatment of disorders of the nervous system, is a research area with a limited number of highly trained neurologists working in drug development. To help fill this gap, the UCB-UNC-Duke Neurology Clinical Development Fellowship program was developed for board certified neurologists seeking further training in neurology drug development.

Dec

03

Approach to big data and machine learning presented at AES

AES_1280_960

Dec

01

Starting From a Patient Perspective Focuses Epilepsy Treatment Progress

As UCB attends the 2018 American Epilepsy Society meeting in New Orleans, Louisiana this week, Mike Davis, Head of UCB’s U.S. Neurology Patient Value Unit, talks about the importance of using innovative approaches to shorten the time it takes a patient to get control of their condition. The following is an excerpt from his LinkedIn article, “Starting from a Patient Perspective Focuses Epilepsy Treatment Progress.” Read the full article on LinkedIn.